Posts

Australia Seeks to Reverse Surge in Syphilis Cases

Syphilis has re-emerged as a major public health threat across Australia, but signs indicate that things might be improving. Medscape News Australia source https://www.medscape.com/viewarticle/australia-seeks-reverse-surge-syphilis-cases-2026a1000nuk?src=rss

Where Have All the Leaders Gone? PAs Want to Step Up

Many PAs are well qualified for leadership roles, but organizational barriers and limited opportunities continue to stand in the way. Medscape Medical News source https://www.medscape.com/viewarticle/where-have-all-leaders-gone-pas-want-step-2026a1000nua?src=rss

Screening for Diabetes at Urgent Care Could Save Lives

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures. Medscape Medical News source https://www.medscape.com/viewarticle/screening-diabetes-urgent-care-could-save-lives-2026a1000npb?src=rss

Getting Blood Into Ambulances Matters in Trauma Cases

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives. Medscape Medical News source https://www.medscape.com/viewarticle/getting-blood-ambulances-matters-trauma-cases-2026a1000np7?src=rss

Can Children Stop Psoriasis Treatment After Remission?

Treatment discontinuation appears to be feasible in children with moderate-to-severe psoriasis for at least 6 months after treatment discontinuation during remission, a study finds. Medscape Medical News source https://www.medscape.com/viewarticle/can-children-stop-psoriasis-treatment-after-remission-2026a1000nin?src=rss

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows. Medscape Medical News source https://www.medscape.com/viewarticle/rituximab-noninferior-ocrelizumab-relapsing-ms-2026a1000nij?src=rss